Overview
Legal name
AUTOLOMOUS LTD
Region
Unknown
Registered address
20-22 WENLOCK ROAD
LONDON
ENGLAND
N1 7GU
Insolvency history
No
Company
Active
LTD
Company profile
Autolomous Ltd
Advanced Therapy Solutions for ATMP Manufacturers
We empower advanced therapy manufacturers to gain new insights and efficiencies within their workflows through our streamlined data management platform.
CRN
11810723
Founded
2019
Age
7
Company events
Reference milestones and recent Companies House filing stream events.
8 events
19 Feb
2027
Confirmation statement due
Confirmation DueNext confirmation statement due date
31 Oct
2026
Accounts due
Accounts DueNext accounts due date
05 Feb
2026
Confirmation statement filed
ConfirmationLast confirmation statement made up date
31 Jan
2025
Accounts filed
AccountsLast accounts made up date
27 Sep
2024
Resolution
ResolutionRESOLUTIONS | Transaction WURDMDkzTjRhZGlxemtjeA | Paper/PDF filed
Published 01 Oct 2024 06:33
27 Sep
2024
Memorandum Articles
IncorporationMA | Transaction MzQzNjUyNzkyNGFkaXF6a2N4 | Paper/PDF filed
Published 01 Oct 2024 06:33
19 Sep
2024
Capital Allotment Shares
CapitalSH01 | Transaction MzQzNjUyNzQwMmFkaXF6a2N4
Published 19 Sep 2024 12:05
06 Feb
2019
Incorporated
InceptionCompany registered at Companies House
Public funding
3 awards
First funded
2021
Funded years
2021, 2023
Age at first award
2 years
Projects
2023
Collaborative R&D
Lead participant
Implementation & digitalisation of Process Analytical Technologies to increase productivity, support rapid release and reduce costs of goods in industrial scale Cell & Gene Therapy (CGT) manufacturing
1 Jun 2023 to 31 May 2025
Awarded
£547,922
Total cost £782,746
In response to the Innovate UK (IUK) Digitalisation and Automation of Medicines R&D and Manufacture grant call, Autolomous and the Cell and Gene Therapy Catapult (CGTC) are proposing a collaboration that aims to enable key stakeholders in the CGT industry (namely therapy developers) to make meaningful progress towards improving manufacturing productivity ...
2021
Innovation Loans
Lead participant
Digitising Cell & Gene Therapy Batch Verification: AUTOLOMATE-Assist
1 Apr 2021 to 31 Mar 2022
Awarded
£712,341
Total cost £712,341
Autolomous is a company founded by Advanced Therapy Medicinal Products (ATMP)- and software development experts, who have combined their skills to deliver elegant solutions to the ATMP supply-chain. The company is creating a platform of software solutions to enable the scheduling of the patient for collection of their cells in a hospital; the transport of...
2021
Collaborative R&D
Lead participant
Empowering the NHS advanced therapies ordering prototype IT system with Manufacturing insight from an electronic batch manufacturing system
1 Apr 2021 to 30 Sep 2022
Awarded
£204,030
Total cost £713,390
Autolomous is a company founded by Advanced Therapy Medicinal Product (ATMP)- and software development experts, who have combined their skills to deliver elegant solutions to the ATMP supply-chain. The company is creating a platform of software solutions to enable the scheduling of the patient for collection of their cells in a hospital; the transport of ...
Product types
Collaborative R&D
Innovation Loans